YOKNEAM, Israel, Aug. 1, 2024/ PRNewswire/-- InMode Ltd., a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended ...

InMode’s products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share ...

Medical devices company InMode (NASDAQ:INMD) has fallen out of favor with investors in the past two years for various reasons, which we'll explain below. However, now that it's down 76% from highs, ...

InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M ...

InMode Ltd. (NASDAQ:INMD) Q2 2025 Earnings Call Transcript July 30, 2025 InMode Ltd. beats earnings expectations. Reported EPS is $0.47, expectations were $0.43. Operator: Good day, and welcome to ...

To the Board Members of InMode: DOMA Perpetual Capital Management is an asset manager focused on generating long-term value for its investors. DOMA is one of the largest shareholders of InMode (the ...